Ascendis Pharma A/S Comprehensive Income
Ascendis Pharma A/S (ASND) reported Comprehensive Income of -EUR 231.57 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Income Statement › Unrealized Gains
ifrs-full:ComprehensiveIncome · last filed 2026-02-11
- Ascendis Pharma A/S comprehensive income for the quarter ending 2025-12-31 was -34.05M EUR.
- Ascendis Pharma A/S comprehensive income for the quarter ending 2025-09-30 was -62.56M EUR.
- Ascendis Pharma A/S comprehensive income for the quarter ending 2025-06-30 was -40.25M EUR.
- Ascendis Pharma A/S comprehensive income for the quarter ending 2025-03-31 was -94.70M EUR.
| Period end | Comprehensive Income 3 month | Comprehensive Income 6 month | Comprehensive Income 9 month | Comprehensive Income 12 month |
|---|---|---|---|---|
| 2025-12-31 | -34.05M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | -96.61M EUR derived: sum of 2 quarters · filed 2026-02-11 | -136.87M EUR derived: sum of 3 quarters · filed 2026-02-11 | -231.57M EUR 20-F · filed 2026-02-11 |
| 2025-09-30 | -62.56M EUR 6-K · filed 2025-11-12 | -102.82M EUR derived: sum of 2 quarters · filed 2025-11-12 | -197.52M EUR 6-K · filed 2025-11-12 | -235.16M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2025-06-30 | -40.25M EUR 6-K · filed 2025-08-07 | -134.96M EUR 6-K · filed 2025-08-07 | -172.59M EUR derived: sum of 3 quarters · filed 2026-02-11 | -271.64M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2025-03-31 | -94.70M EUR 6-K · filed 2025-05-01 | -132.34M EUR derived: sum of 2 quarters · filed 2026-02-11 | -231.38M EUR derived: sum of 3 quarters · filed 2026-02-11 | -340.75M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-12-31 | -37.64M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | -136.68M EUR derived: sum of 2 quarters · filed 2026-02-11 | -246.05M EUR derived: sum of 3 quarters · filed 2026-02-11 | -377.02M EUR 20-F · filed 2026-02-11 |
| 2024-09-30 | -99.04M EUR 6-K · filed 2025-11-12 | -208.41M EUR derived: sum of 2 quarters · filed 2025-11-12 | -339.38M EUR 6-K · filed 2025-11-12 | -427.76M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | -109.36M EUR 6-K · filed 2025-08-07 | -240.34M EUR 6-K · filed 2025-08-07 | -328.71M EUR derived: sum of 3 quarters · filed 2026-02-11 | -490.37M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | -130.97M EUR 6-K · filed 2025-05-01 | -219.35M EUR derived: sum of 2 quarters · filed 2026-02-11 | -381.00M EUR derived: sum of 3 quarters · filed 2026-02-11 | -503.45M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | -88.38M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | -250.03M EUR derived: sum of 2 quarters · filed 2026-02-11 | -372.48M EUR derived: sum of 3 quarters · filed 2026-02-11 | -484.18M EUR 20-F · filed 2026-02-11 |
| 2023-09-30 | -161.65M EUR 6-K · filed 2024-11-14 | -284.10M EUR derived: sum of 2 quarters · filed 2024-11-14 | -395.80M EUR 6-K · filed 2024-11-14 | -601.01M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | -122.45M EUR 6-K · filed 2024-09-03 | -234.15M EUR 6-K · filed 2024-09-03 | -439.36M EUR derived: sum of 3 quarters · filed 2025-02-12 | -610.52M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | -111.70M EUR 6-K · filed 2024-05-02 | -316.91M EUR derived: sum of 2 quarters · filed 2025-02-12 | -488.07M EUR derived: sum of 3 quarters · filed 2025-02-12 | -570.15M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | -205.21M EUR derived: 20-F 12 month − 6-K 9 month · filed 2025-02-12 | -376.37M EUR derived: sum of 2 quarters · filed 2025-02-12 | -458.44M EUR derived: sum of 3 quarters · filed 2025-02-12 | -583.52M EUR 20-F · filed 2025-02-12 |
| 2022-09-30 | -171.16M EUR 6-K · filed 2023-11-07 | -253.24M EUR derived: sum of 2 quarters · filed 2023-11-07 | -378.31M EUR 6-K · filed 2023-11-07 | -483.30M EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-06-30 | -82.08M EUR 6-K · filed 2023-09-05 | -207.15M EUR 6-K · filed 2023-09-05 | -312.14M EUR derived: sum of 3 quarters · filed 2024-02-07 | -391.47M EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-03-31 | -125.07M EUR 6-K · filed 2023-04-27 | -230.06M EUR derived: sum of 2 quarters · filed 2024-02-07 | -309.39M EUR derived: sum of 3 quarters · filed 2024-02-07 | -443.69M EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2021-12-31 | -104.99M EUR derived: 20-F 12 month − 6-K 9 month · filed 2024-02-07 | -184.32M EUR derived: sum of 2 quarters · filed 2024-02-07 | -318.62M EUR derived: sum of 3 quarters · filed 2024-02-07 | -379.72M EUR 20-F · filed 2024-02-07 |
| 2021-09-30 | -79.33M EUR 6-K · filed 2022-11-02 | -213.63M EUR derived: sum of 2 quarters · filed 2022-11-02 | -274.73M EUR 6-K · filed 2022-11-02 | -413.45M EUR derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | -134.30M EUR 6-K · filed 2022-08-10 | -195.40M EUR 6-K · filed 2022-08-10 | -334.12M EUR derived: sum of 3 quarters · filed 2023-02-16 | -455.93M EUR derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | -60.95M EUR 6-K · filed 2022-05-11 | -199.82M EUR derived: sum of 2 quarters · filed 2023-02-16 | -321.64M EUR derived: sum of 3 quarters · filed 2023-02-16 | -416.72M EUR derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | -138.87M EUR derived: 20-F 12 month − 6-K 9 month · filed 2023-02-16 | -260.69M EUR derived: sum of 2 quarters · filed 2023-02-16 | -355.77M EUR derived: sum of 3 quarters · filed 2023-02-16 | -419.00M EUR 20-F · filed 2023-02-16 |
| 2020-09-30 | -121.82M EUR 6-K · filed 2021-11-10 | -216.90M EUR derived: sum of 2 quarters · filed 2021-11-10 | -280.13M EUR 6-K · filed 2021-11-10 | -360.53M EUR derived: sum of 4 quarters · filed 2022-03-02 |
| 2020-06-30 | -95.08M EUR 6-K · filed 2021-08-27 | -158.31M EUR 6-K · filed 2021-08-27 | -238.71M EUR derived: sum of 3 quarters · filed 2022-03-02 | -263.79M EUR derived: sum of 4 quarters · filed 2022-03-02 |
| 2020-03-31 | -63.23M EUR 6-K · filed 2021-05-27 | -143.63M EUR derived: sum of 2 quarters · filed 2022-03-02 | -168.71M EUR derived: sum of 3 quarters · filed 2022-03-02 | -228.21M EUR derived: sum of 4 quarters · filed 2022-03-02 |
| 2019-12-31 | -80.40M EUR derived: 20-F 12 month − 6-K 9 month · filed 2022-03-02 | -105.48M EUR derived: sum of 2 quarters · filed 2022-03-02 | -164.97M EUR derived: sum of 3 quarters · filed 2022-03-02 | -218.05M EUR 20-F · filed 2022-03-02 |
| 2019-09-30 | -25.08M EUR 6-K · filed 2020-11-12 | -84.57M EUR derived: sum of 2 quarters · filed 2020-11-12 | -137.65M EUR 6-K · filed 2020-11-12 | -169.60M EUR derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-06-30 | -59.50M EUR 6-K · filed 2020-08-27 | -112.58M EUR 6-K · filed 2020-08-27 | -144.52M EUR derived: sum of 3 quarters · filed 2021-03-10 | -178.50M EUR derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-03-31 | -53.08M EUR 6-K · filed 2020-05-19 | -85.02M EUR derived: sum of 2 quarters · filed 2021-03-10 | -119.00M EUR derived: sum of 3 quarters · filed 2021-03-10 | -141.77M EUR derived: sum of 4 quarters · filed 2021-03-10 |
| 2018-12-31 | -31.95M EUR derived: 20-F 12 month − 6-K 9 month · filed 2021-03-10 | -65.92M EUR derived: sum of 2 quarters · filed 2021-03-10 | -88.70M EUR derived: sum of 3 quarters · filed 2021-03-10 | -130.08M EUR 20-F · filed 2021-03-10 |
| 2018-09-30 | -33.98M EUR 6-K · filed 2019-11-18 | -56.75M EUR derived: sum of 2 quarters · filed 2019-11-18 | -98.14M EUR 6-K · filed 2019-11-18 | -132.29M EUR derived: sum of 4 quarters · filed 2020-04-03 |
| 2018-06-30 | -22.77M EUR 6-K · filed 2019-08-28 | -64.16M EUR 6-K · filed 2019-08-28 | -98.31M EUR derived: sum of 3 quarters · filed 2020-04-03 | -132.19M EUR derived: sum of 4 quarters · filed 2020-04-03 |
| 2018-03-31 | -41.38M EUR 6-K · filed 2019-05-30 | -75.53M EUR derived: sum of 2 quarters · filed 2020-04-03 | -109.42M EUR derived: sum of 3 quarters · filed 2020-04-03 | -140.08M EUR derived: sum of 4 quarters · filed 2020-04-03 |
| 2017-12-31 | -34.15M EUR derived: 20-F 12 month − 6-K 9 month · filed 2020-04-03 | -68.03M EUR derived: sum of 2 quarters · filed 2020-04-03 | -98.70M EUR derived: sum of 3 quarters · filed 2020-04-03 | -123.83M EUR 20-F · filed 2020-04-03 |
| 2017-09-30 | -33.88M EUR 6-K · filed 2018-11-28 | -64.55M EUR derived: sum of 2 quarters · filed 2018-11-28 | -89.68M EUR 6-K · filed 2018-11-28 | |
| 2017-06-30 | -30.66M EUR 6-K · filed 2018-08-29 | -55.80M EUR 6-K · filed 2018-08-29 | ||
| 2017-03-31 | -25.14M EUR 6-K · filed 2018-05-30 | |||
| 2016-12-31 | -68.50M EUR 20-F · filed 2019-04-03 | |||
| 2015-12-31 | -32.94M EUR 20-F · filed 2018-03-28 |